Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

Alberto E. Tozzi, Chiara Aizari, Giorgio Bartolozzi, Susanna Esposito, Gaetano Maria Fara, Milena Lo Giudice

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit. Information based on evidence is necessary for correctly planning schedules and for parents who often fear the administration of too many vaccines. We reviewed the available literature to assess the effects on immunogenicity and safety of simultaneous administration of hexavalent and conjugate pneumococcal and meningococcal C vaccines in healthy children. Methods: We searched for papers including a comparison of coadministration and single administration of hexavalent with conjugate pneumococcal or meningococcal C vaccines. Data sources included Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE. Immunogenicity and safety results were extracted and compared. We calculated the absolute risk increase of being a non responder to any antigen and of experiencing common adverse events. Results: Four relevant articles were included in the review. Immunogenicity of components included in the hexavalent vaccines was maintained with coadministration of conjugate pneumococcal and meningococcal C vaccines. However individuals who received hexavalent vaccine with conjugate pneumococcal vaccines were 18% more likely to have anti-PRP <1 μg/mL after the third dose although this difference disappeared after the fourth dose, and titres against meningococcal C antigens were higher when vaccines were administered separately. Children who received simultaneous administration of hexavalent vaccines with conjugate pneumococcal vaccines had a 13-17% additional risk of experiencing fever compared with single administration. Conclusion: Few studies deal with coadministration of vaccines. Hexavalent and conjugate pneumococcal or meningococcal vaccines may however be administered simultaneously without noteworthy negative effects on immunogenicity or safety profile. Parents of vaccinees should be appropriately informed on the effects of coadministration to improve their compliance. Studies on vaccine coadministration should be promoted and unpublished studies realized for vaccine registration should be made available.

Original languageEnglish
Pages (from-to)252-259
Number of pages8
JournalHuman Vaccines
Volume3
Issue number6
Publication statusPublished - Nov 2007

Fingerprint

Meningococcal Vaccines
Conjugate Vaccines
Vaccines
Pneumococcal Vaccines
Safety
Parents
Antigens
Immunization Programs
Information Storage and Retrieval
MEDLINE
Compliance
Fear
Appointments and Schedules
Vaccination
Fever
Databases

Keywords

  • Coadministration
  • Conjugate meningococcal C vaccines
  • Conjugate pneumococcal vaccines
  • Hexavalent vaccines
  • Immunogenicity
  • Tolerability
  • Trial disclosure

ASJC Scopus subject areas

  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Tozzi, A. E., Aizari, C., Bartolozzi, G., Esposito, S., Fara, G. M., & Giudice, M. L. (2007). Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines? Human Vaccines, 3(6), 252-259.

Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines? / Tozzi, Alberto E.; Aizari, Chiara; Bartolozzi, Giorgio; Esposito, Susanna; Fara, Gaetano Maria; Giudice, Milena Lo.

In: Human Vaccines, Vol. 3, No. 6, 11.2007, p. 252-259.

Research output: Contribution to journalArticle

Tozzi, AE, Aizari, C, Bartolozzi, G, Esposito, S, Fara, GM & Giudice, ML 2007, 'Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?', Human Vaccines, vol. 3, no. 6, pp. 252-259.
Tozzi, Alberto E. ; Aizari, Chiara ; Bartolozzi, Giorgio ; Esposito, Susanna ; Fara, Gaetano Maria ; Giudice, Milena Lo. / Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?. In: Human Vaccines. 2007 ; Vol. 3, No. 6. pp. 252-259.
@article{54b38ea641514cd583339e56f30e233f,
title = "Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?",
abstract = "Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit. Information based on evidence is necessary for correctly planning schedules and for parents who often fear the administration of too many vaccines. We reviewed the available literature to assess the effects on immunogenicity and safety of simultaneous administration of hexavalent and conjugate pneumococcal and meningococcal C vaccines in healthy children. Methods: We searched for papers including a comparison of coadministration and single administration of hexavalent with conjugate pneumococcal or meningococcal C vaccines. Data sources included Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE. Immunogenicity and safety results were extracted and compared. We calculated the absolute risk increase of being a non responder to any antigen and of experiencing common adverse events. Results: Four relevant articles were included in the review. Immunogenicity of components included in the hexavalent vaccines was maintained with coadministration of conjugate pneumococcal and meningococcal C vaccines. However individuals who received hexavalent vaccine with conjugate pneumococcal vaccines were 18{\%} more likely to have anti-PRP <1 μg/mL after the third dose although this difference disappeared after the fourth dose, and titres against meningococcal C antigens were higher when vaccines were administered separately. Children who received simultaneous administration of hexavalent vaccines with conjugate pneumococcal vaccines had a 13-17{\%} additional risk of experiencing fever compared with single administration. Conclusion: Few studies deal with coadministration of vaccines. Hexavalent and conjugate pneumococcal or meningococcal vaccines may however be administered simultaneously without noteworthy negative effects on immunogenicity or safety profile. Parents of vaccinees should be appropriately informed on the effects of coadministration to improve their compliance. Studies on vaccine coadministration should be promoted and unpublished studies realized for vaccine registration should be made available.",
keywords = "Coadministration, Conjugate meningococcal C vaccines, Conjugate pneumococcal vaccines, Hexavalent vaccines, Immunogenicity, Tolerability, Trial disclosure",
author = "Tozzi, {Alberto E.} and Chiara Aizari and Giorgio Bartolozzi and Susanna Esposito and Fara, {Gaetano Maria} and Giudice, {Milena Lo}",
year = "2007",
month = "11",
language = "English",
volume = "3",
pages = "252--259",
journal = "Human Vaccines",
issn = "1554-8600",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

AU - Tozzi, Alberto E.

AU - Aizari, Chiara

AU - Bartolozzi, Giorgio

AU - Esposito, Susanna

AU - Fara, Gaetano Maria

AU - Giudice, Milena Lo

PY - 2007/11

Y1 - 2007/11

N2 - Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit. Information based on evidence is necessary for correctly planning schedules and for parents who often fear the administration of too many vaccines. We reviewed the available literature to assess the effects on immunogenicity and safety of simultaneous administration of hexavalent and conjugate pneumococcal and meningococcal C vaccines in healthy children. Methods: We searched for papers including a comparison of coadministration and single administration of hexavalent with conjugate pneumococcal or meningococcal C vaccines. Data sources included Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE. Immunogenicity and safety results were extracted and compared. We calculated the absolute risk increase of being a non responder to any antigen and of experiencing common adverse events. Results: Four relevant articles were included in the review. Immunogenicity of components included in the hexavalent vaccines was maintained with coadministration of conjugate pneumococcal and meningococcal C vaccines. However individuals who received hexavalent vaccine with conjugate pneumococcal vaccines were 18% more likely to have anti-PRP <1 μg/mL after the third dose although this difference disappeared after the fourth dose, and titres against meningococcal C antigens were higher when vaccines were administered separately. Children who received simultaneous administration of hexavalent vaccines with conjugate pneumococcal vaccines had a 13-17% additional risk of experiencing fever compared with single administration. Conclusion: Few studies deal with coadministration of vaccines. Hexavalent and conjugate pneumococcal or meningococcal vaccines may however be administered simultaneously without noteworthy negative effects on immunogenicity or safety profile. Parents of vaccinees should be appropriately informed on the effects of coadministration to improve their compliance. Studies on vaccine coadministration should be promoted and unpublished studies realized for vaccine registration should be made available.

AB - Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit. Information based on evidence is necessary for correctly planning schedules and for parents who often fear the administration of too many vaccines. We reviewed the available literature to assess the effects on immunogenicity and safety of simultaneous administration of hexavalent and conjugate pneumococcal and meningococcal C vaccines in healthy children. Methods: We searched for papers including a comparison of coadministration and single administration of hexavalent with conjugate pneumococcal or meningococcal C vaccines. Data sources included Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE. Immunogenicity and safety results were extracted and compared. We calculated the absolute risk increase of being a non responder to any antigen and of experiencing common adverse events. Results: Four relevant articles were included in the review. Immunogenicity of components included in the hexavalent vaccines was maintained with coadministration of conjugate pneumococcal and meningococcal C vaccines. However individuals who received hexavalent vaccine with conjugate pneumococcal vaccines were 18% more likely to have anti-PRP <1 μg/mL after the third dose although this difference disappeared after the fourth dose, and titres against meningococcal C antigens were higher when vaccines were administered separately. Children who received simultaneous administration of hexavalent vaccines with conjugate pneumococcal vaccines had a 13-17% additional risk of experiencing fever compared with single administration. Conclusion: Few studies deal with coadministration of vaccines. Hexavalent and conjugate pneumococcal or meningococcal vaccines may however be administered simultaneously without noteworthy negative effects on immunogenicity or safety profile. Parents of vaccinees should be appropriately informed on the effects of coadministration to improve their compliance. Studies on vaccine coadministration should be promoted and unpublished studies realized for vaccine registration should be made available.

KW - Coadministration

KW - Conjugate meningococcal C vaccines

KW - Conjugate pneumococcal vaccines

KW - Hexavalent vaccines

KW - Immunogenicity

KW - Tolerability

KW - Trial disclosure

UR - http://www.scopus.com/inward/record.url?scp=37649019001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37649019001&partnerID=8YFLogxK

M3 - Article

C2 - 17881905

AN - SCOPUS:37649019001

VL - 3

SP - 252

EP - 259

JO - Human Vaccines

JF - Human Vaccines

SN - 1554-8600

IS - 6

ER -